Loading clinical trials...

Young Adult Hypertension Self-Management Clinical Trial | Clinical Trials | Clareo Health

COMPLETEDNA

Young Adult Hypertension Self-Management Clinical Trial

The MyHEART Study: A Young Adult Hypertension Self-Management Randomized Controlled Trial

NCT03158051•University of Wisconsin, Madison

Summary

This is a 5-year randomized controlled trial in two large healthcare systems (Madison and Milwaukee, WI) to evaluate MyHEART's (My Hypertension Education And Reaching Target) impact on blood pressure among 310 geographically and racially/ethnically diverse young adults.

Detailed Description

Aim 1. To evaluate the effect of MyHEART (home blood pressure monitor distribution and heath coaching) on clinical outcomes, the change in systolic and diastolic blood pressure (primary) and hypertension control (secondary) after 6 and 12 months, compared to usual clinical care. Aim 2. To evaluate the effect of MyHEART on hypertension self-management behavior (behavioral outcomes) at 6 and 12 months, compared to usual clinical care. Aim 3. To examine whether MyHEART's effects on self-management behavior are mediated through variables of perceived competence, autonomy, motivation, and activation (mediation outcomes).

Eligibility

Age

18 - 39 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Willing and capable of giving written informed consent
•Willing to comply with all study procedures and be available for the duration of the study
•Males and females ages 18-39 years old at the start of the study (inclusive)
•A minimum of two hypertension ICD-10 coded visits with a provider (physician \[MD, DO\], physician assistant, nurse practitioner) on different dates in the last 24 months, with at least one code in the past 18 months
•Medically homed at an IRB approved healthcare system

Exclusion Criteria

•History of medically determined Congestive Heart Failure
•Unable to provide informed consent (i.e., activated healthcare power of attorney)
•Unable or unwilling to travel to local clinic for research visits
•Currently residing in a skilled nursing facility
•Diagnosed with sickle cell anemia or cystic fibrosis
•Diagnosed with stroke, myocardial infarction, and/or coronary artery revascularization in the past 2 years
•Syncope while exercising or doing strenuous activity within past 12 months
•Currently prescribed warfarin, novel oral anticoagulant, or insulin
•Planned organ transplant or prior transplant in the past 5 years
•Chemotherapy or radiation therapy within 6 the past months
+13 more criteria

Locations (2)

University of Wisconsin School of Medicine & Public Health

Madison, Wisconsin, United States

Aurora Health Care

Milwaukee, Wisconsin, United States

Key Dates

Start Date

October 2, 2017

Primary Completion Date

January 13, 2022

Completion Date

February 8, 2022

Last Updated

May 17, 2023

Enrollment

316

ACTUAL participants

Conditions

HypertensionBlood PressureLifestyle Risk Reduction

Interventions

Home Blood Pressure Monitoring

BEHAVIORAL

Telephone Health Coaching

BEHAVIORAL

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITINGNA

Transcutaneous Auricular Vagus Nerve Stimulation and Spirometry: Sham-Controlled Randomized Trial

NCT07482930

Vagus Nerve StimulationsSpirometry+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 17, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Young Adult Hypertension Self-Management Clinical Trial

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

Transcutaneous Auricular Vagus Nerve Stimulation and Spirometry: Sham-Controlled Randomized Trial

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Penn Medicine Healthy Heart